OBIO (OBIO)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from OBIO's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from OBIO's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | $4M | $3M | $3M | $33M |
| Net income | -$378,753 | -$34M | -$49M | -$61M | -$53M |
| Free cash flow | — | -$30M | -$46M | -$51M | -$49M |
| EPS (diluted) | -$0.04 | -$2.24 | -$1.48 | -$1.66 | -$1.11 |
| Operating margin | — | -924.3% | -1866.2% | -2437.5% | -154.7% |
Where the revenue comes from
Revenue by products, fiscal 2025. Every breakdown, year by year.
Superinvestors who own OBIO
From each investor's latest 13F filing (what a 13F shows).
Insider buying
Open-market purchases by OBIO's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Sep 3, 2026 | David P Hochman Director |
10,000 | $4.79 | $47,900 |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when OBIO trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are OBIO insiders buying the stock?
1 open-market insider purchase of OBIO in the last 12 months, from SEC Form 4 filings.
Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.